Itxaso Garcia-Orue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Itxaso Garcia-Orue has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Manoli Igartua
NanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, Vitoria-Gasteiz 01006, Spain; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, Madrid 28029, Spain; Bioaraba, NanoBioCel Research Group, Vitoria-Gasteiz 01006, Spain
8 shared publications - Rosa Maria Hernandez
NanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain
8 shared publications Garazi Gainza
Biopraxis Research AIE, Miñano, Vitoria-Gasteiz, Spain
4 shared publications- José Luis Pedraz
NanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Department of Pharmacy and Food Science, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain
4 shared publications - Edorta Santos-Vizcaino
NanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain
3 shared publications - José Javier Aguirre
Hospital Universitario de Álava (HUA) Txagorritxu, Vitoria-Gasteiz 01009, Spain
3 shared publications
Latest Publications
- Open Access
- 14 April 2021
- Published by MDPI AG in Pharmaceuticals
- Vol. 14 (4) , 362
3D Bioprinting of Functional Skin Substitutes: From Current Achievements to Future Goals
The aim of this review is to present 3D bioprinting of skin substitutes as an efficient approach of managing skin injuries. From a clinical point of view, classic treatments only provide physical protection from the environment, and existing engineered scaffolds, albeit acting as a physical support for cells, fail to overcome needs, such as neovascularisation. In the present work, the basic principles of bioprinting, together with the most popular approaches and choices of biomaterials for 3D-printed skin construct production, are explained, as well as the main advantages over other production methods. Moreover, the development of this technology is described in a chronological manner through examples of relevant experimental work in the last two decades: from the pioneers Lee et al. to the latest advances and different innovative strategies carried out lately to overcome the well-known challenges in tissue engineering of skin. In general, this technology has a huge potential to offer, although a multidisciplinary effort is required to optimise designs, biomaterials and production processes.
- 14 April 2021
- Published by MDPI AG in Pharmaceuticals
- Vol. 14 (4) , 362
Open Access3D Bioprinting of Functional Skin Substitutes: From Current Achievements to Future Goals
The aim of this review is to present 3D bioprinting of skin substitutes as an efficient approach of managing skin injuries. From a clinical point of view, classic treatments only provide physical protection from the environment, and existing engineered scaffolds, albeit acting as a physical support for cells, fail to overcome needs, such as neovascularisation. In the present work, the basic principles of bioprinting, together with the most popular approaches and choices of biomaterials for 3D-printed skin construct production, are explained, as well as the main advantages over other production methods. Moreover, the development of this technology is described in a chronological manner through examples of relevant experimental work in the last two decades: from the pioneers Lee et al. to the latest advances and different innovative strategies carried out lately to overcome the well-known challenges in tissue engineering of skin. In general, this technology has a huge potential to offer, although a multidisciplinary effort is required to optimise designs, biomaterials and production processes.
- Open Access
Characterization of Bio-Inspired Electro-Conductive Soy Protein Films
Protein-based conductive materials are gaining attention as alternative components of electronic devices for value-added applications. In this regard, soy protein isolate (SPI) was processed by extrusion in order to obtain SPI pellets, subsequently molded into SPI films by hot pressing, resulting in homogeneous and transparent films, as shown by scanning electron microscopy and UV-vis spectroscopy analyses, respectively. During processing, SPI denatured and refolded through intermolecular interactions with glycerol, causing a major exposition of tryptophan residues and fluorescence emission, affecting charge distribution and electron transport properties. Regarding electrical conductivity, the value found (9.889 × 10−4 S/m) is characteristic of electrical semiconductors, such as silicon, and higher than that found for other natural polymers. Additionally, the behavior of the films in contact with water was analyzed, indicating a controlled swelling and a hydrolytic surface, which is of great relevance for cell adhesion and spreading. In fact, cytotoxicity studies showed that the developed SPI films were biocompatible, according to the guidelines for the biological evaluation of medical devices. Therefore, these SPI films are uniquely suited as bioelectronics because they conduct both ionic and electronic currents, which is not accessible for the traditional metallic conductors.
Open AccessCharacterization of Bio-Inspired Electro-Conductive Soy Protein Films
Protein-based conductive materials are gaining attention as alternative components of electronic devices for value-added applications. In this regard, soy protein isolate (SPI) was processed by extrusion in order to obtain SPI pellets, subsequently molded into SPI films by hot pressing, resulting in homogeneous and transparent films, as shown by scanning electron microscopy and UV-vis spectroscopy analyses, respectively. During processing, SPI denatured and refolded through intermolecular interactions with glycerol, causing a major exposition of tryptophan residues and fluorescence emission, affecting charge distribution and electron transport properties. Regarding electrical conductivity, the value found (9.889 × 10−4 S/m) is characteristic of electrical semiconductors, such as silicon, and higher than that found for other natural polymers. Additionally, the behavior of the films in contact with water was analyzed, indicating a controlled swelling and a hydrolytic surface, which is of great relevance for cell adhesion and spreading. In fact, cytotoxicity studies showed that the developed SPI films were biocompatible, according to the guidelines for the biological evaluation of medical devices. Therefore, these SPI films are uniquely suited as bioelectronics because they conduct both ionic and electronic currents, which is not accessible for the traditional metallic conductors.
- Open Access
- 4 July 2019
- Published by MDPI AG in Pharmaceutics
- Vol. 11 (7) , 314
Development of Bioinspired Gelatin and Gelatin/Chitosan Bilayer Hydrofilms for Wound Healing
In the current study, we developed a novel gelatin-based bilayer wound dressing. We used different crosslinking agents to confer unique properties to each layer, obtaining a bioinspired multifunctional hydrofilm suitable for wound healing. First, we produced a resistant and non-degradable upper layer by lactose-mediated crosslinking of gelatin, which provided mechanical support and protection to overall design. For the lower layer, we crosslinked gelatin with citric acid, resulting in a porous matrix with a great swelling ability. In addition, we incorporated chitosan into the lower layer to harness its wound healing ability. FTIR and SEM analyses showed that lactose addition changed the secondary structure of gelatin, leading to a more compact and smoother structure than that obtained with citric acid. The hydrofilm was able to swell 384.2 ± 57.2% of its dry weight while maintaining mechanical integrity. Besides, its water vapour transmission rate was in the range of commercial dressings (1381.5 ± 108.6 g/m2·day). In vitro, cytotoxicity assays revealed excellent biocompatibility. Finally, the hydrofilm was analysed through an ex vivo wound healing assay in human skin. It achieved similar results to the control in terms of biocompatibility and wound healing, showing suitable characteristics to be used as a wound dressing.
- 4 July 2019
- Published by MDPI AG in Pharmaceutics
- Vol. 11 (7) , 314
Open AccessDevelopment of Bioinspired Gelatin and Gelatin/Chitosan Bilayer Hydrofilms for Wound Healing
In the current study, we developed a novel gelatin-based bilayer wound dressing. We used different crosslinking agents to confer unique properties to each layer, obtaining a bioinspired multifunctional hydrofilm suitable for wound healing. First, we produced a resistant and non-degradable upper layer by lactose-mediated crosslinking of gelatin, which provided mechanical support and protection to overall design. For the lower layer, we crosslinked gelatin with citric acid, resulting in a porous matrix with a great swelling ability. In addition, we incorporated chitosan into the lower layer to harness its wound healing ability. FTIR and SEM analyses showed that lactose addition changed the secondary structure of gelatin, leading to a more compact and smoother structure than that obtained with citric acid. The hydrofilm was able to swell 384.2 ± 57.2% of its dry weight while maintaining mechanical integrity. Besides, its water vapour transmission rate was in the range of commercial dressings (1381.5 ± 108.6 g/m2·day). In vitro, cytotoxicity assays revealed excellent biocompatibility. Finally, the hydrofilm was analysed through an ex vivo wound healing assay in human skin. It achieved similar results to the control in terms of biocompatibility and wound healing, showing suitable characteristics to be used as a wound dressing.
- 1 February 2019
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 556, 320-329
Composite nanofibrous membranes of PLGA/Aloe vera containing lipid nanoparticles for wound dressing applications
- 1 February 2019
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 556, 320-329
Composite nanofibrous membranes of PLGA/Aloe vera containing lipid nanoparticles for wound dressing applications
- 1 December 2017
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 42, 2-17
Nanotechnology-based delivery systems to release growth factors and other endogenous molecules for chronic wound healing
- 1 December 2017
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 42, 2-17
Nanotechnology-based delivery systems to release growth factors and other endogenous molecules for chronic wound healing
- 1 May 2017
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 523 (2) , 556-566
Novel nanofibrous dressings containing rhEGF and Aloe vera for wound healing applications
- 1 May 2017
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 523 (2) , 556-566
Novel nanofibrous dressings containing rhEGF and Aloe vera for wound healing applications
- 1 November 2016
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 108, 310-316
LL37 loaded nanostructured lipid carriers (NLC): A new strategy for the topical treatment of chronic wounds
- 1 November 2016
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 108, 310-316
LL37 loaded nanostructured lipid carriers (NLC): A new strategy for the topical treatment of chronic wounds
- 1 January 2016
- Published by Elsevier
- p. 31-55
Nanotechnology approaches for skin wound regeneration using drug-delivery systems
- 1 January 2016
- Published by Elsevier
- p. 31-55
Nanotechnology approaches for skin wound regeneration using drug-delivery systems
- 1 October 2015
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 103, 370-373
New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization
- 1 October 2015
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 103, 370-373
New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization